News

Two High-Potential Stocks to Buy Now for Up to 40% Upside

Real Estate

Two High-Potential Stocks to Buy Now for Up to 40% Upside

Discover two promising stocks from the real estate and oil & gas sectors, recommended by Trade Brains Portal, with potential gains of up to 40%.

August 6, 2025
Read Article
George Hongchoy to Step Down as CEO of Asia’s Largest REIT After 16 Years

real estate news

George Hongchoy to Step Down as CEO of Asia’s Largest REIT After 16 Years

George Hongchoy, the head of Link Asset Management Ltd., the manager of Asia’s largest real estate investment trust, plans to retire after a successful 16-year tenure. During his leadership, the LINK REIT has more than doubled the Hang Seng Index, returning 10.2% annually including dividends.

July 22, 2025
Read Article
Investing in ONGC, Bank of Baroda, and 3 Other Undervalued Stocks: A Smart Move?

real estate news

Investing in ONGC, Bank of Baroda, and 3 Other Undervalued Stocks: A Smart Move?

ONGC, Bank of Baroda, and three other stocks are currently trading below their book value, presenting a potential opportunity for savvy investors. Discover whether these stocks are worth adding to your portfolio now.

March 31, 2025
Read Article
ONGC PetroAdditions Shifts Focus to Domestic Market, Exits SEZ

Real Estate

ONGC PetroAdditions Shifts Focus to Domestic Market, Exits SEZ

ONGC PetroAdditions, a subsidiary of ONGC, is re-strategizing its operations by exiting the Special Economic Zone (SEZ) to focus more on the domestic market. This decision is part of a broader initiative to enhance domestic production and reduce dependenc

March 9, 2025
Read Article
Budget Day Market Highlights: Nifty Ends Close to 23,500, FMCG Stocks Outperform

real estate news

Budget Day Market Highlights: Nifty Ends Close to 23,500, FMCG Stocks Outperform

In a volatile trading session on Budget day, the Nifty managed to close near 23,500. FMCG stocks took the lead, with ONGC, Sun Pharma, LIC Housing Finance, Aster DM, Nuvama Wealth Management, Karnataka Bank, and Pfizer performing notably.

February 2, 2025
Read Article